Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FGL2 |
| Upstream (Parents) |
|---|
| (<<) GIMAP4 → FGL2 |
| (<<) HCLS1 → FGL2 |
| Downstream (Children) |
|---|
| FGL2 → NOS2 (>>) |
| FGL2 → XAF1 (>>) |
| FGL2 → LOC652637///WHAMML1 (>>) |
| FGL2 → CTSS (>>) |
| FGL2 → XCL2///XCL1 (>>) |
| FGL2 → KLRB1 (>>) |
| FGL2 → NKG7 (>>) |
| FGL2 → TRAJ17///TRAV20///TRD@///TRA@ (>>) |
| FGL2 → GZMK (>>) |
| FGL2 → BAIAP2L2 (>>) |
| FGL2 → GZMA (>>) |
| FGL2 → FAIM3 (>>) |
| FGL2 → CD40LG (>>) |
| FGL2 → CD3D (>>) |
| FGL2 → CX3CR1 (>>) |
| FGL2 → RASGRP2 (>>) |
| FGL2 → TARP///TRGC2 (>>) |
| FGL2 → CD96 (>>) |
| FGL2 → FYB (>>) |
| FGL2 → IL2RB (>>) |
| FGL2 → CSTA (>>) |
| FGL2 → ATP8B4 (>>) |
| FGL2 → FCN1 (>>) |
| FGL2 → CD226 (>>) |
| FGL2 → SURF2 (>>) |
| FGL2 → CXADR (>>) |
| FGL2 → PLEKHF1 (>>) |
| FGL2 → PPDPF (>>) |
